Small Cap Company Stock To Watch Out After Dolly Khanna Ups Stake

[ad_1]

Read More/Less


Investment

oi-Roshni Agarwal

|

As per bulk deals data on the BSE, ace investor Dolly Khanna seems bullish on the scrip of Simran Farms and has bought stake in the firm twice in the last 1-week. Khanna today bought 19642 shares at a price of Rs. 167.96 per share. While the scrip in today’s trade (November 29, 2021) settled at a price of Rs. 173.45 per share, hitting 5 percent upper circuit on the BSE. The scrip is not traded on the NSE.

Small Cap Company Stock To Watch Out After Dolly Khanna Ups Stake

Small Cap Company Stock To Watch Out After Dolly Khanna Ups Stake

On November 24, 2021 also, Khanna bought 22,344 shares in the scrip at a price of Rs. 135.19 apiece.

The competitive strength as highlighted are the company’s increasing net cash flow and cash from operating activity. In a 1-year period the scrip has generated return of 160%, while on a year to date basis, the stock’s return are at 150%.

The small cap company, founded in the year 1984, turned into a public limited company in the year 1993. Indore, MP based company is committed to providing nutritional poultry products.

In the recently concluded September quarter of Fy 22, the company’s income from operations surged QoQ to Rs. 112.44 crore, while net profit declined to Rs. 3.07 crore as against Rs. 5.69 crore in the June ended quarter.

Some of the company’s listed peers include Venkys, Uniroyal Marine and Ovobel Foods among others.

GoodReturns.in

Story first published: Monday, November 29, 2021, 23:35 [IST]



[ad_2]

CLICK HERE TO APPLY

India Inc’s CSR spend declines sharply to ₹8,828.11 crore in FY’20-21

[ad_1]

Read More/Less


Call this COVID19 pandemic effect. India Inc’s Corporate Social responsibility (CSR) spend for FY 2020-21 fell sharply to ₹8,828.11 crore, much lower than the cumulative spends of ₹20,150.27 crore in FY2018-19 and ₹24,688.66 crore in FY 2019-20, official data submitted to Parliament on Monday showed.

An analysis of CSR filings made by the companies revealed that of the total annual CSR spent, about 60 per cent of the CSR expenditure has been done through implementation agencies, said Rao Inderjeet Singh, Minister of State for Corporate Affairs in a written reply to Lok Sabha question.

In India, the CSR architecture is disclosure based and only CSR mandated companies are required to file details of CSR spent annually in the MCA-21 registry.

In FY 2020-21, as many as 1,619 companies have done CSR spend of ₹8,828.21 crore. Of these, as many as 1,599 are non-PSUs, while 20 are PSUs. Non PSUs spend for CSR in 2020-21 stood at ₹8,266.93 crore, while the 20 PSUs cumulatively spent ₹, 561.18 crore, as per available official data up to September 30 this year.

Interestingly, in previous years of 2019-20 and 2018-19, as many as 22,531 and 25,099 companies respectively spent ₹24,688.66 crore and ₹20,150.27 crore towards CSR.

Under the Act, CSR is a Board driven process and the Board of the company is empowered to plan, decide, execute and monitor CSR activities based on the recommendations of the CSR committee. The government does not issue any specific direction to the companies to spend in any particular activity or area.

[ad_2]

CLICK HERE TO APPLY

2 Pharma Stocks To Buy For Short Term For Potential Upside Up To 17%: ICICI Direct

[ad_1]

Read More/Less


1. Biocon: Buy Biocon for 3 months for a target of Rs. 425

ICICI Direct suggest to ‘Buy’ Biocon for a price target of Rs. 425 per share for a 3 month investment horizon. The stop loss recommended is Rs. 327. This implies potential investors into the scrip of Biocon considering the last traded price of Rs. 364.4 apiece can earn returns of 16.76 percent.

Note the brokerage has listed Biocon as its Quant pick and recommends the buy in the scrip of Biocon in the price range of Rs. 360-368.

Brokerage’s take on the pharma sector

The pharma space has witnessed healthy consolidation in the last couple of weeks amid a broader market movement. “We believe the sector is set to resume its next round of upside move”, says the brokerage.

View on Biocon scrip as put by ICICI Direct

The open interest in Biocon is continuously declining. We believe the stock should resume its upward momentum in the near term on the back of continued short covering.

The open interest in Biocon has been declining gradually in the last couple of months. The current open interest in the stock is one of the lowest in the current calendar year and the stock has been trading with a positive bias. We believe short positions are getting closed and continued short covering is expected, which should prompt further up move in the stock.

On the options front, the stock has the highest Call option base at the 370 strike. As the stock is trading near this levels, closure of positions is evident at ATM strikes and positions are moving at higher OTM strike. We expect continued upsides in the stock in the coming sessions.

“After its quarterly results the stock of Biocon has performed relatively well compared to most pharma stocks and declines were used to accumulate further. Significant delivery based buying was observed in the stock in the range of Rs. 350-360 in the November series. We expect these levels to act as major support for the stock in coming weeks the coming weeks.

Biocon has been consolidating below its long term mean levels for almost a year. Also, considering ongoing delivery based activity, we believe it may surpass its mean levels currently near Rs.375. In such a scenario, stock movement towards its mean+1*sigma levels is expected in the coming weeks”, adds the brokerage.

2. Cipla: Buy Cipla for a target price of Rs. 1060

2. Cipla: Buy Cipla for a target price of Rs. 1060

As its Gladiator stock pick, the brokerage house has advised to buy the scrip of Cipla in the price range of Rs. 935-950. The target price set out for the stock is Rs. 1060, implying an upside of 11.58 percent from the scrip’s last traded price of Rs. 965. Stop loss suggested for the investment is Rs. 888. Remember duration for the buy in the scrip is again 3 months.

On the pharma index, the brokerage firm said that the index took a breather over the last 3 months after having shown outperformance during CY 2020-21.

Cipla showed resilience wherein it consolidated in a broader range (Rs. 1000-870) while sustaining above 200 day’s EMA. Currently, it staged strong buying demand from the lower band of consolidation. Hence, it offers a fresh entry opportunity with favourable risk reward.

Key observation on Cipla

“The stock has shown faster retracement on the smaller degree chart as it retraced past six week’s consolidation in just a single week highlighting robust price structure that augurs well for the next leg of up move. We expect the stock to resolve higher and gradually head towards our target of Rs. 1060 in the coming month as it is the 138.2% external retracement September-November decline (Rs.1005-883). On the oscillator front, weekly RSI has generated a buy signal moving above its nine period’s average, indicating positive bias”, adds the brokerage.

Disclaimer:

Disclaimer:

The stocks listed are taken from the brokerage report of ICICI Direct. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.

GoodReturns.in



[ad_2]

CLICK HERE TO APPLY

Branches added by banks in FY21 at a decade low

[ad_1]

Read More/Less


 

Banks added only 1,383 branches in FY2021, the lowest in a decade, as banking via alternative channels such as digital and Business Correspondents (BCs) gained traction amid the Covid-19 pandemic.

Banks had expanded their branch network by 7,728 in FY20, according to RBI data.

Another reason for the fewer branch additions in FY21 was that five large public sector banks (PSBs) — Bank of Baroda, Punjab National Bank, Canara Bank, Union Bank of India and Indian Bank — went in for branch consolidation following amalgamation of select PSBs with them.

As at March-end 2021, the network of offices of scheduled commercial banks increased to 1,54,485 from 1,53,102 as at March-end 2020, as per RBI data.

Given that alternative banking channels are gaining popularity as they offer the convenience of banking at customers’ fingertips (mobile and internet banking) as well as doorstep banking via BCs, Banks’ will go slow on expansion of brick-and-mortar branches to save on costs, say industry experts.

 

EASE of banking

The latest EASE (Enhanced Access and Service Excellence) report underscored that through improvements in digital channels, most branch-based services are now accessible to the customers from home and mobile, including in local languages.

This has enabled convenient access to banking services, including during the nationwide lockdown imposed due to the pandemic.

“Encouraged by the convenience and quality of experience on these channels, many PSB customers have increasingly adopted them for day-to-day banking needs. “Seventy-six per cent of all the financial transactions across PSBs are now undertaken through home and mobile channels such as mobile banking application, internet banking platform, call centre, etc,” the report said.

Besides augmenting the broad-based use of technology, the Covid-19 pandemic has fuelled the proliferation of digital modes of payment, propelling the country towards ‘less-cash’ alternatives.

Mobile banking

“Bank’s mobile application will be the primary interface for customers. Apart from a few services which are best delivered at a branch, customers will increasingly be using mobile phones for meeting banking requirements.

“The endeavour is to have a right mix of physical and digital infrastructure. The Bank is looking at significantly expanding its presence across locations through new BCs and lighter formats,” Sanjiv Chadha, MD & CEO, Bank of Baroda, said in the FY21 annual report.

As part of the integration of Vijaya Bank and Dena Bank with BoB, the latter merged or rationalised 1,310 branches and 1,135 ATMs during FY21.

Rajkiran Rai G, MD & CEO, Union Bank of India (UBI), highlighted the cost synergy that can be achieved by way of optimisation of physical distribution of network through branch & ATM network merger/ rationalisation, employee alignment, among others, in the Bank’s annual report.

Following the amalgamation of Andhra Bank and Corporation Bank with UBI, the latter merged 277 branches in FY21.

[ad_2]

CLICK HERE TO APPLY

Cashfree Payments invests $15 million in UAE-based Telr

[ad_1]

Read More/Less


Payments and API banking solutions company Cashfree Payments has made an equity investment of $15 million in Telr, a Payment Service Provider (PSP) in UAE and Saudi Arabia.

With this investment, Cashfree has become the single largest stakeholder in Telr. This strategic investment will enable Cashfree to launch its offerings in the MENA region on the back of Telr’s presence and payment infrastructure. The two companies also plan to build a cross-border payments platform to help Indian merchants accept payments from customers in the MENA region and vice-versa.

Growing market

Akash Sinha, CEO and Co-Founder, Cashfree Payments told BusinessLine, “The entire West Asian market is growing rapidly when it comes to digitisation. The MENA region is witnessing a continuous transition towards cashless transactions, with traditional brick-and-mortar businesses moving towards expanding online offerings. Today, less than 2 per cent of retail purchases in these countries happen online. So, there is a huge market opportunity.”

He added that another reason for this investment is that today a lot of Indian businesses are going global, and West Asia is one of the popular expansion locations among these companies. “The intention here is that once a company starts working with Cashfree, they will have a seamless transition whenever they go to other geographies across the world. And, companies will not have to go look for new banking partners in these new countries,” Sinha noted.

Cashfree’s pay-outs offering is integrated into the payments flows of internet businesses like Cred, Dream11, Acko, Xiaomi and Nykaa among others. The six-year-old company claims to be profitable for the past four financial years.

Founded in 2014, Telr is a UAE-based payment gateway solutions provider. It enables handling payments in over 120 currencies and 30 languages in a secured fashion.

[ad_2]

CLICK HERE TO APPLY

Padmaja Reddy questions collection efficiency of Spandana Sphoorty in Q2

[ad_1]

Read More/Less


Padmaja Reddy, founder and former Managing Director of Spandana Sphoorty Financial, has questioned the collection efficiency figures for the second quarter of the fiscal and has claimed that no loans have been disbursed by the microfinance player in November.

Spandana had reported standalone collection efficiency for the quarter ended September 30, at 105 per cent and 113 per cent for the month of September, including pre-payments. Excluding these, the standalone collection efficiency was 97 per cent for the entire quarter and 99 per cent for the month, respectively.

Former Spandana MD Padmaja Reddy questions high salary being paid to new MD and CEO

However, Reddy said the actual collection efficiency, excluding overdue collections (funded by new loan disbursements), even after not considering the demand of 22.6 per cent of the loans restructured, was 92.5 per cent and 92.4 per cent for the second quarter and the month of September, respectively.

“If the demand of restructured loans is considered, collection efficiency for the quarter was 75.7 per cent,” she said.

The company had restructured 5.2 lakh borrower accounts with an outstanding of ₹1,602 crore till September 30, she further said.

Noting that no loans have been disbursed from November 1 till date, Reddy said that if the situation prevails, the collection efficiency, which is less than 80 per cent in November would get further impacted.

She also said processing of insurance claims too has come to standstill.

“We get approximately 3,000 insurance claims a month. Not even a single insurance claim has been sent to the insurance company since November 2,” she said.

Spandana’s response

In response to an e-mail query from BusinessLine, the board of Spandana Sphoorty said it is working diligently to ensure a smooth transition that will continue to build on a fundamentally strong business.

“The board is in touch with all stakeholders to address any concerns. It is unfortunate that Reddy, who resigned as MD on November 2, and continues to be a director, is issuing such communications. While it is possible to assume she is disgruntled at her term as MD not being extended from May when her current employment contract expires, her resigning immediately on being told about the board’s decision not to renew her employment agreement, and then making such statements is, in the company’s opinion, uncalled for and potentially harmful to the company she has built over the past nearly 20 years,” it further said.

It also stressed that one individual’s comments cannot undermine the board’s fiduciary responsibility to all stakeholders.

“If Reddy was really concerned about the company and its future, she as a board member has the ability to constructively participate in all strategic discussions. Unfortunately, she is not doing so in the recent past,” it further said.

The micro finance company is yet to announce its second quarter results, but expects to do so shortly.

Healthy performance

In a business update on November 22, Spandana had said the company has demonstrated healthy performance in the quarter that ended September 30.

“For the partial month of November, till November 16, the company collected approximately ₹400 crore (standalone basis), which includes approximately ₹30 crore of advance collections done at the end of October related to loan instalments due in November,” it had said.

[ad_2]

CLICK HERE TO APPLY

UP police files FIR against SREI promoters, directors

[ad_1]

Read More/Less


The Uttar Pradesh police has registered a first information report (FIR) against crisis-ridden SREI Group’s promoters and directors of its certain companies for an alleged bank fraud. The FIR was registered at a police station at Kautwali Jaunpur, Uttar Pradesh on the basis of a complaint filed by one Bhupendra Nath.

The Jaunpur police station has now forwarded the matter to the Economic Offences Wing (EOW).

The Jaunpur Police has, in the FIR, named 22 directors and promoters of SREI Group under U/S-420/ 467/ 468/ 471/ 474/ 476/ 323/ 504/ 506/ 511 R/w-120-B of Indian Penal Code.

When contacted, brothers Hemant Kanoria and Sunil Kanoria, former promoters of SREI Infrastructure Finance, said they were not aware of any such FIR.

It maybe recalled that the Reserve Bank of India had, on October 4, superseded the board of SREI Infrastructure Finance Ltd (SIFL) and SREI Equipment Finance Limited, owing to governance concerns and defaults by the the two companies in meeting their various payment obligations. Rajneesh Sharma, Ex- Chief General Manager of Bank of Baroda, was appointed as Administrator of these companies.

FIR COMPLAINT

The FIR has been registered upon the complaint of one Bhupendra Nath who went to Srei-run Jan Suvidha Kendra for some work, and there he was allegedly duped by the employees of Srei. Bhupendra Nath found that many alleged criminal activities were being carried out at the Jan Suvidha Kendra, including bank fraud of more than ₹16,000 crore. He also reported the fact that at the Jan Suvidha Kendras, money was charged at the whims and fancies of the employees and the amount varied from ₹1,000 to ₹2,5000 for the works which are either free or for which a very nominal fee of not more than ₹100 is charged.

Initially, he filed the police complaint and seeing no effective action he approached the court with 4,000-5,000 pages documentary evidence; upon which the Chief Judicial Magistrate ordered the registration of FIR against the accused persons. The 29-pages of the FIR covers detailed methodology as to how the Jan Suvidha Kendras are run and also how the alleged bank fraud to the tune of ₹16,000 crore was perpetrated through such Kendras.

[ad_2]

CLICK HERE TO APPLY

RBI appoints additional director on board of Ujjivan SFB

[ad_1]

Read More/Less


The Reserve Bank of India has appointed P.N. Raghunath, General Manager, Reserve Bank of India, as an Additional Director on the board of Ujjivan Small Finance Bank for a period of two years.

“…we hereby inform you that the Reserve Bank of India vide its letter dated November 29, 2021, has appointed PN Raghunath, General Manager, Reserve Bank of India, Bengaluru, Regional Office, as an Additional Director on the board of the bank for a period of two years with effect from November 29, 2021 to November 28, 2023 or till further orders, whichever is earlier,” Ujjivan SFB said in a stock exchange filing on Monday.

Previously, the RBI had on September 16 appointed a special committee of directors, with three independent directors as members, to oversee the day-to-day operations.

The bank has been facing some amount of turmoil in recent months. Its Managing Director and CEO, Nitin Chugh, resigned earlier this year.

The lender has also had problems with asset quality as gross non-performing assets surged to Rs 1,712.65 crore or 11.8 per cent of gross advances as on September 30, 2021.

[ad_2]

CLICK HERE TO APPLY

India1 Payments deploys over 10,000 White Label ATMs

[ad_1]

Read More/Less


India1 Payments Ltd (formerly BTI Payments Pvt Ltd) has crossed the ATM deployment milestone of 10,000 White Label ATMs.

K Srinivas, Managing Director and Chief Executive Officer, India1 Payments, said, “With an average deployment of over 300 ATMs per month for the previous four months, we are committed to ensuring cash availability to customers even in the remotest corners of the country.”

The Bengaluru-headquartered company is planning an initial public offer comprising fresh issue of equity shares aggregating up to ₹150 crore and offer for sale of up to 1.03 crore equity shares,

ATMs deployed by White Label ATM Operators (WLAOs) reached over 25,000 in number with a strong CAGR of 21 per cent between March 2015 and March 2021, as per the company’s draft red herring prospectus (DRHP)

CRISIL Research expects the number of ATMs deployed by WLAs to grow at a compounded annual growth rate of 17 per cent between March 2021 and March 2026, to reach 55,000 by March 2026.

[ad_2]

CLICK HERE TO APPLY

Bharti AXA Life new business premium up 33% in H1

[ad_1]

Read More/Less


Bharti AXA Life Insurance, a private life insurer, on Monday said that the company’s weighted new business premium grew 33 per cent in the first half this fiscal to ₹285 crore (₹214 crore).

The company recorded 8 per cent growth in its renewal premium to ₹645 crore (₹594 crore).

Total premium income grew moderately to ₹1,024 crore in the April-September 2021 period from ₹912 crore in the first six months of the last financial year.

The company recorded growth of 53 per cent in weighted new business premium in the month of September 2021 and outperformed the private sector by 1.5X.

Parag Raja, Managing Director and Chief Executive Officer, Bharti AXA Life Insurance, said in a statement, “We have registered steady performance on many parameters and achieved one of the highest industry growth for our new business premium collection in the first six months of the current financial year. Further, our asset under management saw a strong growth of 28 per cent and has doubled over the past three years”.

Surge in business

The improvement in the Covid pandemic situation since August 2021, buoyant consumer sentiment towards the need for life insurance and the company’s investments in digital platforms to enhance customer experience and facilitate seamless services along with the suite of customer-centric products gives “us confidence about achieving our business targets and growth in the coming months.”

The 13th month persistency ratio for Bharti AXA Life insurance improved to 64.4 per cent in H1-FY22, up from 60.7 per cent for the same period last year.

The Company’s solvency ratio stood at 188 per cent on September 30, 2021, well above the regulatory requirement of 150 per cent. The company recorded a surge of 28 per cent in its asset under management at ₹10,256 crore as on September 30, 2021 against ₹7,987 crore in the corresponding period of the last fiscal.

The company has disbursed ₹106 crore in Covid related claims for the first half of the financial year 2022.

Bharti AXA Life Insurance has 254 branches and33,266 advisors as on September 30, 2021.

“We have already witnessed a strong start with our new bancassurance partners — Fincare Small Finance Bank, Shivalik Bank and Utkarsh Small Finance Bank, and are actively pursuing opportunities for strategic tie-ups and alliances to ensure sustained business growth over the next few years,” Raja said.

[ad_2]

CLICK HERE TO APPLY

1 22 23 24 25 26 16,279